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Purpose: To investigate impact of distribution of computed tomography (CT) emphysema on
severity of airflow limitation and gas exchange impairment in current and former heavy
smokers participating in a lung cancer screening trial.
Materials and Methods: In total 875 current and former heavy smokers underwent baseline
low-dose CT (30 mAs) in our center and spirometry and diffusion capacity testing on the same
day as part of the DutcheBelgian Lung Cancer Screening Trial (NELSON). Emphysema was quan-
tified for 872 subjects as the number of voxels with an apparent lowered X-ray attenuation
coefficient. Voxels attenuated <950 HU were categorized as representing severe emphysema
(ES950), while voxels attenuated between 910 HU and 950 HU represented moderate
emphysema (ES910). Impact of distribution on severity of pulmonary function impairment
was investigated with logistic regression, adjusted for total amount of emphysema.
Results: For ES910 an apical distribution was associated with more airflow obstruction and gas
exchange impairment than a basal distribution (both p< 0.01). The FEV1/FVC ratio was 1.6%
(95% CI 0.42% to 2.8%) lower for apical predominance than for basal predominance, for
Tlco/VA the difference was 0.12% (95% CI 0.076e0.15%). Distribution of ES950 had no impact
on FEV1/FVC ratio, while an apical distribution was associated with a 0.076% (95% CI 0.038e
0.11%) lower Tlco/VA (p< 0.001).t of Radiology, University Medical Center, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
098.
recht.nl (H.A. Gietema).
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Distribution of emphysema in heavy smokers 77Conclusion: In a heavy smoking population, an apical distribution is associated with more
severe gas exchange impairment than a basal distribution; for moderate emphysema it is also
associated with a lower FEV1/FVC ratio. However, differences are small, and likely clinically
irrelevant.
ª 2009 Elsevier Ltd. All rights reserved.Introduction
Chronic obstructive pulmonary disease (COPD) is the most
frequent chronic disease in developed countries and is pre-
dicted to be the third cause of death in 2020.1 COPD is
a multicomponent disease comprising a combination of small
airways disease (bronchiolitis) and parenchyma destruction
(emphysema)2 and characterized by airflow limitation
assessed by spirometry. One of the limitations of spirometry,
but also of diffusion capacity testing, is its inherent global
character, while distribution of disease may be an important
factor in the severityandprogressionofairflow limitation 3 and
gas exchange impairment. Computed tomography (CT) can
non-invasively provide anatomical information about the
location and the extent of emphysema and has been shown to
correlate well with histology.4e7 Due to its non-invasive char-
acter it is also an attractive method to study changes in
emphysema and airway disease over time. The National
Emphysema Treatment Trial (NETT) has shown that not the
extent of emphysema, but the distribution of emphysema is
one of the predicting factors for the survival rate of severe
COPD patients.8
Previous studies have suggested that subjects with
a similar degree of parenchyma destruction can show
different degrees of airflow limitation and gas exchange
impairment dependent on the location of the damage in the
lungs.9 The impact of these patterns of emphysema distri-
bution has been investigated in patients with a1-antitrypsin
deficiency (AATD) suffering from severe emphysema,9 but
these results cannot easily be extrapolated to smoking
related COPD. An earlier study among unselected smokers
could only demonstrate an association between distribution
pattern (i.e. apical or basal predominance of emphysema)
and pulmonary function for subjectively (i.e. visually)
quantified extent of lung destruction, but not for automated
quantified emphysema.10 However, the sample size of this
study was relatively small and only a part of the lungs was
analyzedwith the automatedmethod.We hypothesized that
we would be able to demonstrate the impact of emphysema
distribution on pulmonary function parameters studying
a large sample of heavy smokers with overlapping CT data.
The aim the current study was to investigate the impact of
emphysema distribution on severity of airflow limitation and
gas exchange impairment in a population of current and
former heavy smokers participating in a lung cancer screening
trial.
Material and methods
Subjects
The NELSON-trial (Nederlands-Leuvens longScreenings
ONderzoek) is a population based randomized DutcheBelgianmulti-center lung cancer screening trial, studying current and
former heavy smokers. The trial was approved by the Dutch
ministry of health and by the ethics committee of each
participating hospital. Selection of subjects for the trial was
performed by sending out a questionnaire about smoking
history and other health-related issues to people between 50
and 75 years of age, living in the areas around the partici-
pating centers.11 Subjects, who met the inclusion criterion of
a minimum of 16 cigarettes/day for 25 years or 11 cigarettes/
day for 30 years and gave written informed consent, were
equally randomized to either the screening armor the control
arm. Before inviting eligible subjects, persons with
a moderate or poor self-reported health status who were
unable to climb two flights of stairs were excluded from
participation.
From 2997 subjects who underwent baseline screening in
our hospital, about one out of three was randomly selected
for pulmonary function testing on the same day. This was
done due to logistic considerations.
Pulmonary function tests
Pulmonary function tests (PFT) included forced expiratory
volume in 1 s (FEV1) and forced vital capacity (FVC) with
a pneumotachograph and assessment of diffusion capacity
(Tlco), according to ERS guidelines.12 No reversibility
testing was performed. Diffusing capacity measurements
were performed after spirometry. The inhalation mixture
contained 0.3% CO and 10% He with balance air. Results
were expressed as percentages of predicted values.
CT scanning and calculation emphysema scores
CT scans were performed on a multidetector-row scanner
(Mx8000 IDT or Brilliance 16P, Philips Medical Systems,
Cleveland, OH, USA). All scans were realized within 12 s, in
spiral mode with 16 0.75 mm collimation, 1.0 mm recon-
struction thickness with 0.7 mm increment, without
contrast-injection. Exposure settings were 30 mAs at
120 kVp for subjects weighing 80 kg or 30 mAs at 140 kVp
for those weighing over 80 kg, without dose modulation.
Scans were performed in end-inspiration.
Scans were transferred to a digital workstation with in-
house developed software (ImageXplorer (iX) Image
Sciences Institute, Utrecht, The Netherlands).13 A fully
automated region-growing program segmented both lungs
starting from the trachea and including all connected areas
with attenuated below 500 HU. In a next step, airways
were segmented and excluded. The algorithm is similar to
the one described by Hu et al.14 Finally, segmented lungs
were subjected to a noise filter.15 The extent of emphy-
sema was estimated using the threshold technique quanti-
fying the percent of the total lung voxels with an apparent
Table 1
Item
ES910
Mean 8.6%
SD 2.7e22.0%
ES950
Mean 0.12%
SD 0.04e0.4%
Age (years)
Mean 60.0
SD 5.5
Height (cm)
Mean 177.7
SD 7.5
Pack-years
Mean 40.7
SD 16.1
FEV1
Mean 98.5%
SD 87.3e109.2%
Vital capacity
Mean 105.6%
SD 97.0e114.3%
FEV1/FVC
Mean 96.0%
SD 87.7e101.8%
Tlco/VA (% predicted)
Median 83.2%
Intequartile range 71.8e93.5%
Descriptive statistics for the total study population shown as
mean values and standard deviations (SD). Emphysema scores
represent percentages of total lung volume. All lung function
parameters are expressed as percentage of the predicted value.
78 H.A. Gietema et al.X-ray attenuation value below to predefined thresholds
(950 Hounsfield units (HU) and 910 HU). Lung areas with
an attenuation between 910 HU and 950 HU (ES910) were
considered to represent moderate emphysema, while lung
volume with an attenuation below 950 HU (ES950) were
considered to represent severe emphysema.4,8 Emphysema
scores (ES) were given as percentage of total lung volume in
a range from 0% to 100%.
Distribution of emphysema and statistics
We calculated means, standard deviations (SD) and 95%
confidence intervals (CI) for normal distributed parameters
and medians and interquartile ranges for non-normal
distributed parameters.
The lungs were divided into three parts with equal
volumes (top, middle and lower part) and ES910 and ES950
were calculated for each part. Since none of the subjects
showed the middle part to be the main area for emphyse-
matous changes, we compared the extent of emphysema in
the top and lower parts. Distribution of emphysema for both
ES910 and ES950 was assessed by subtracting the extent of
emphysema in the lower part from the extent of emphysema
in the top part of the lungs. A positive result was considered
a predominant apical distribution; a negative result was
considered a predominant basal distribution.
Impact of distribution pattern on pulmonary function
parameters was assessed via analysis of variance, adjusted
for differences in ES910/ES950, sex, age and height in both
distribution groups. Analysis was repeated on a subgroup of
subjects including only subjects with FEV1/FVC< 0.7.
Since many subjects had an apical predominance for
ES910 and a basal predominance for ES950, while their
pulmonary function results are independent of the applied
density threshold, we performed the analyses again
including only those subjects who had an apical predomi-
nance or a basal predominance for both levels of lung
destruction and therefore a consistent distribution pattern.
All statistics were calculated with SPSS statistical soft-
ware package version 15.0 (SPSS, Chicago, Ill.). p-Values
<0.05 were considered significant.
Results
Subjects
Eight hundred and seventy-five subjects (50e74 years,
mean 62 years), 453 current smokers and 422 former
smokers completed all tests. Three subjects were excluded
from further analysis, because the software failed to
calculate their emphysema scores. Since the NELSON trial
started enrollment with only male (former) smokers, the
vast majority of subjects (828; 95%) in the current study
were male. Characteristics of the study subjects are shown
in Table 1 for the total study population and in Table 2 split
by distribution pattern.
In total 625 subjects (72%) had a consistent distribution
pattern for both levels of lung parenchyma destruction,
including 179 (29%) subjects with an apical predominance
and 445 (71%) subjects with a basal predominance. These
625 subjects had a difference in emphysema scoresbetween the upper and lower parts of the lungs of 2.5%
(13.4%) for ES910 and 0.91% (6.2%) for ES950. For those
subjects who had their distribution pattern to differ
dependent on the applied density threshold (nZ 247),
differences between emphysema scores in the upper parts
of the lungs and emphysema scores in the lower parts of the
lungs were smaller: 0.59% (5.25%) for ES910 (pZ 0.005)
and 0.01% (1.29%) for ES950 (pZ 0.001).
Moderate emphysema
Mean extent of moderate emphysema was 13.9% (14.1%)
ranging from 0.0% to 67.0%. ES910 was not related to
smoking history in pack-years or to FEV1/FVC for the total
study population, while it was weakly related to Tlco/VA
(rZ0.31; p< 0.001). For subjects with a FEV1/FVC ratio
<0.7 only, emphysema and FEV1/FVC were weakly associ-
ated (rZ0.39, p< 0.001).
Two hundred and fifty-five subjects (29%) had
a predominant apical distribution pattern of moderate
emphysema; 617 (71%) subjects had a predominant basal
Table 2
Apical
predominance
Basal
predominance
Moderate emphysema
Number of subjects 255 617
Emphysema score
Mean 14.6% 7.2%
SD 4.4e30.1% 2.3e18.5%
Age (years)
Mean 60.3 59.9
SD 5.6 5.5
Height (cm)
Mean 176.7 178.1
SD 8.1 7.2
Pack-years
Mean 41.7 41.0
SD 15.8 16.3
FEV1 (% predicted)
Median 98.5% 98.6%
Interquartile range 85.1e109.2% 87.8e109.2%
Vital capacity
(% predicted)
Median 108.9% 104.7%
Interquartile range 99.6e118.3% 13.9%
FEV1/FVC (% predicted)
Median 92.9% 97.0%
Interquartile range 84.4e99.9% 89.2e102.3%
Tlco/VA (% predicted)
Median 76.5% 104.7%
Interquartile range 64.0e88.0% 96.0e113.2%
Severe emphysema
Number of subjects 315 521
Emphysema score
Mean 0.1% 0.12%
SD 0.02e0.8% 0.05e0.31%
Age (years)
Mean 59.9 60.1
SD 5.3 5.6
Height (cm)
Mean 177.2 177.9
SD 8.0 7.2
Pack-years
Mean 42.4 40.5
SD 15.4 16.7
FEV1 (% predicted)
Median 98.2% 98.4%
Interquartile range 87.2e108% 87.6e110%
Vital capacity
(% predicted)
Median 104% 107%
Interquartile range 96.1e114.0% 97.1e115%
Table 2 (continued )
Apical
predominance
Basal
predominance
FEV1/FVC (% predicted)
Median 96.9% 95.4%
Interquartile range 87.5e103% 87.7e101%
Tlco/VA (% predicted)
Median 80.3% 84.8%
Interquartile range 67.8e90.9% 75.2e94.1%
Descriptive statistics shown as mean values and standard devi-
ations (SD) for normal distributed data and as median and
interquartile range for non-normal distributed ones, broken
down by distribution pattern. Emphysema scores represent
percentages of total lung volume. All lung function parameters
are expressed as percentage of the predicted value. Moderate
emphysema is detected as lung volume with an attenuation
between 950 HU and 910 HU; severe emphysema is detected
as lung volume with an attenuation below 950 HU.
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sema was associated with a lower FEV1/FVC ratio compared
to basal distribution (p< 0.001). Subjects with an apical
predominance showed a FEV1/FVC ratio that was 1.60%
(95% CI 0.50e3.28%) lower than the FEV1/FVC ratio in
subjects with a basal predominance. An apical predomi-
nance was also associated with a slightly lower Tlco/VA
compared to a basal predominance (p< 0.001); subjects
with an apical predominance showed a ratio that was 0.12%
(95% CI 0.076e0.15%) lower than the Tlco/VA ratio in
subjects with a basal predominance.
The subgroup of 314 subjects with a FEV1/FVC ratio <0.7
showed no impact of emphysema distribution pattern on
FEV1/FVC (pZ 0.11), but also in this subgroup an apical
predominance was also associated with a lower Tlco/VA
compared to a basal predominance (p< 0.001); subjects
with an apical predominance showed a ratio that was 0.15%
(95% CI 0.089e0.20%) lower than the Tlco/VA ratio in
subjects with a basal predominance.
In the subgroup of 625 subjects with the same distribu-
tion pattern for both levels of lung parenchyma destruc-
tion, an apical distribution was significantly associated with
a lower FEV1/FVC ratio (p< 0.001); subjects with an apical
predominance had a ratio that was 3.2% (95% CI 1.5e5.0%)
lower than in those with a basal predominance. An apical
distribution was also significantly associated with a lower
Tlco/VA ratio (p< 0.001), being 0.17% (95% CI 0.13e0.21%)
lower compared to the Tlco/VA ratio in subjects with
a basal predominance.
Severe emphysema
Mean extent of severe emphysema was 0.86% (2.9%)
ranging from 0.0% to 30.7%. ES950 was not related to
smoking history in pack-years or to FEV1/FVC for the total
study population, while it was weakly related to Tlco/VA
(rZ0.35; p< 0.001). For subjects with a FEV1/FVC ratio
<0.7 only, FEV1/FVC was moderately associated to extent
of emphysema (rZ0.45, p< 0.001) Three hundred and
fifty-one subjects (40%) had an apical prominent
80 H.A. Gietema et al.distribution pattern of moderate emphysema, 521 subjects
(60%) had a predominant basal distribution.
No impact of distribution of severe emphysema on FEV1/
FVC could be detected. For diffusion capacity, an apical
distribution was associated with a lower Tlco/VA ratio
(p< 0.001) compared to a basal distribution. Subjects with
an apical predominance showed a Tlco/VA ratio, which was
0.076% (95% CI 0.038e0.11%) lower than the ratio in
subjects with a basal distribution pattern.
The subgroup of 314 subjects with a FEV1/FVC ratio <0.7
showed again no impact of emphysema distribution pattern
on FEV1/FVC (pZ 0.71), but an apical predominance was
also associated with a lower Tlco/VA compared to a basal
predominance (p< 0.001); subjects with an apical
predominance showed a ratio that was 0.13% (95% CI
0.076e0.18%) lower than the Tlco/VA ratio in subjects with
a basal predominance.
Only in the subgroup of subjects with the same distri-
bution pattern for both levels of lung parenchyma
destruction, an apical distribution was significantly associ-
ated with a lower FEV1/FVC ratio (pZ 0.03); subjects with
an apical predominance had a ratio that was 1.7% (95% CI
0.16e3.2%) lower than in those with a basal predominance.
In this subgroup, an apical distribution was also significantly
associated with a lower Tlco/VA ratio (p< 0.001), with
a Tlco/VA ratio that was 0.14% (95% CI 0.09e0.18%) lower in
subjects with an apical predominance than in those with
a basal predominance.
Fig. 1 shows two subjects with a similar extent of CT
emphysema, but with different distributions and spirom-
etry results.Discussion
In this study we studied a large sample of relatively healthy
current and former heavy smokers with overlapping 1.0 mm
thin CT images to investigate the impact of emphysema
distribution on lung function parameters. We used two
density thresholds commonly used to estimate the extentFigure 1 A) 62 Year old male subject, ES950 9.0%, FEV1%Z
FEV1%Z 112%; KcoZ 83%.of CT emphysema and reported that the chosen density
threshold had only limited impact on the results. Our
results also showed that in these relatively healthy current
and former heavy smokers, the emphysema distribution
pattern has a significant, but small and therefore likely
clinically irrelevant, impact on lung function parameters.
By analyzing only subjects with a FEV1/FVC ratio <0.7, the
outcome didn’t show major changes and can therefore not
be explained by the large number of subjects with normal
lung function parameters. When analyzing only those
subjects with a consistent distribution pattern for both
levels of lung parenchyma destruction and thereby
excluding subjects with a more homogeneous distribution
pattern, the impact of distribution pattern became slightly
clearer, but it remained relatively small.
COPD is a multicomponent disease compromising paren-
chyma destruction (emphysema) and large and small airways
disease.2 We only investigated lung destruction, not airway
wall thickness, in a relatively healthy study group with on
average a low extent of lung destruction and didn’t show any
correlation between the extent of destructed lung tissue and
severity of airway obstruction, irrespective of the applied
density threshold. This lack of correlation could be caused by
the narrow range of spirometry results, but it is also possible
that the severity of airway obstruction in the investigated
population with early stages of COPDwasmainly determined
by the extent of airways disease.
An impact of distribution pattern was to be expected
since both ventilation and perfusion of the lungs is not
equally distributed throughout the lungs. Both ventilation
and blood flow per unit volume decrease from the bottom
to the top of the upright lung. However, the changes for
blood flow are more marked than those for ventilation.
Destruction of lung tissue in the upper zones will therefore
result in a greater mismatch of ventilation and perfusion
than destruction of lung tissue in than lower zones, which
explains the worse diffusion capacity for subjects with
apical predominant destruction compared to subjects with
the same extent of emphysema, but basal predominant
disease.45%; KcoZ 47%. B) 52 Year old male subject, ES950 8.2%,
Distribution of emphysema in heavy smokers 81The better perfusion and ventilation of the lower parts of
the lungs compared to the perfusion and ventilation of the
upper parts of the lungs can also result in a better compen-
sationmechanism in the early stages of destruction, as in our
study population. In cases of very severe emphysema, the
healthy tissue cannot compensate for the destructed parts
any more, resulting in severe pulmonary function impair-
ment with a bad prognosis as reported in the NETT.8
For the spirometry, the role of small airway disease may
be important. Kim et al. showed that that impact of upper
zone emphysema on FEV1/VC ratio is greater than the
impact of lower zone emphysema, which may be caused by
the difference in the degree of small airway disease
(SAD).16 While emphysema was not equally distribution
throughout the lungs, a similar pattern can be expected for
airway disease. Therefore, subjects with upper zone
predominant emphysema may also have more severe small
airway disease in their upper lobes, resulting in more
airflow limitation.
Several other study groups have investigated the impact
of emphysema distribution on severity of airflow limitation
before, with conflicting results. Investigating 59 heavy
smokers, Gurney et al. reported that the Tlco and TLC
showed stronger correlations with basal emphysema than
with apical emphysema, but the FEV1 and FEF25e75 showed
the highest correlations with apical emphysema. However,
these differences were only significant for visually quanti-
fied emphysema, but not for extent of emphysema esti-
mated by a computer. The authors hypothesized that
a sampling bias may be a reason for the differences
between both techniques. We used overlapping CT images,
so sampling bias was not an issue in this study. The obser-
vation that we were able to demonstrate a small impact of
distribution pattern of automated quantified CT emphy-
sema on pulmonary function parameters in relatively
healthy smokers may be due to the larger sample size.
A study by Parr et al. in patients with a1-antitrypsine defi-
ciency showed that the Tlco/VA ratio was stronger influ-
enced by upper zone emphysema and the FEV1 by lower
zone emphysema.9 Interestingly, in a subsequent longitu-
dinal study they reported that lower zone emphysema was
associated with stronger progression in gas exchange
impairment, while upper lobe predominant emphysema
was associated with stronger decline in FEV1.
3 These results
indicate that progression over time is influenced by other
factors than baseline results and may e.g. be stronger in
areas that are less diseased at baseline due to spread of the
disease throughout the lungs.
Saitoh et al. reported in a study in 62 subjects with
a prior diagnosis of emphysema, that the FEV1/VC showed
the strongest correlations for with lower lung emphy-
sema.17 Haraguchi et al. included 25 subjects with known
emphysema and reported that the Tlco correlated slightly
better with middle and basal emphysema, while the FEV1
showed the best correlation (rZ 0.64) with basal emphy-
sema only.18 Nakano concluded in their study of 73 male
patients with a prior diagnosis of COPD that the Tlco/VA was
stronger influenced by upper-inner and middle-inner
emphysema and the FEV1/VC by lower-inner and lower-
outer emphysema.19 However Aziz et al. could not
demonstrate any significant correlations in a retrospective
study in 101 subjects with evidence of emphysema.20These conflicting results show that the impact of
emphysema distribution on lung function parameters is not
clear yet and seem to be highly dependent on patient
characteristics of the investigated study population (known
emphysema or not, severity of airflow limitation, sample
size and scanning technique). We included a large sample
of study subjects and used volumetric data, excluding
sample bias and power limitations.
Our study suffers from some limitations. The subjects
included in the current analysis were relatively healthy.
The subjects included in the NETT trial are severely
diseased and in that cohort, distribution of emphysema has
been shown to have an important impact on survival.
Analyzing only more severe diseased subjects in our study
sample did not show major changes in the reported results.
The current analysis was a cross-sectional study, therefore
we did not study the impact of distribution of emphysema
on progression of disease and survival rate. Like in AATD
patients, distribution of emphysema may have a different
impact on progression of disease.
In conclusion, in contrast to the results reported for
AATD patients, distribution pattern of emphysema in
current and former heavy smokers has a small and likely not
clinically relevant impact on lung function parameters,
with slightly worse pulmonary function results for those
with an apical predominance.
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